Product Overview
CTP is one of the four ribonucleotide substrates used in IVT reactions, where it is incorporated opposite guanine in the DNA template. Because every nucleotide in the reaction contributes to the yield and purity of the mRNA, the quality of each one matters. For mRNA vaccines, gene therapy products, and other nucleic acid-based therapeutics, the raw material also has to meet the documentation and consistency expectations of regulated manufacturing. CTP Sodium Solution is a high-purity nucleotide substrate manufactured in a GMP-compliant production environment, with a completely animal-origin-free process throughout the workflow. It is designed for IVT, mRNA synthesis, nucleic acid drug development, and GMP-scale manufacturing of mRNA-based therapeutics, supporting applications from preclinical research to commercial-scale production.
The product has a purity of >99%, with rigorous quality control, controlled impurity levels, and ultra-low metal residues to meet demanding research and production requirements. High batch-to-batch consistency supports scalable manufacturing, and DMF filing support is available for regulatory and commercial development needs. CTP Sodium Solution is part of a complete nucleotide product portfolio covering diverse mRNA synthesis requirements, and customized specifications and supply solutions can be discussed according to process development and manufacturing needs. The product should be transported below 0°C and stored at -25°C to -15°C.
Product Features
- High purity with stringent quality control: Purity is above 99%, with rigorous quality control, controlled impurity levels, and ultra-low metal residues for reliable performance in IVT and mRNA manufacturing workflows.
- GMP-compliant, animal-origin-free manufacturing with DMF support: The product is made in a GMP-compliant production system with comprehensive quality control procedures and a completely animal-origin-free process. High batch-to-batch consistency supports scalable manufacturing, and DMF filing support is available for regulatory and commercial development needs.
- Flexible supply and customization: CTP Sodium Solution belongs to a complete nucleotide portfolio for mRNA synthesis, and customized specifications and supply solutions are available to match different process development and manufacturing needs.
FAQ
Q1: What is CTP Sodium Solution used for?
It is primarily used as a nucleotide substrate for in vitro transcription (IVT), mRNA synthesis, mRNA vaccine development and manufacturing, nucleic acid drug R&D, gene therapy drug development, and GMP-scale production of mRNA therapeutics, from preclinical research to commercial manufacturing.
Q2: Is it suitable for GMP manufacturing, and what regulatory support is available?
The product is manufactured in a GMP-compliant production environment with strict quality control and supports applications from preclinical development to commercial-scale manufacturing. The entire manufacturing workflow is animal-origin-free, and DMF filing support is available for regulatory and commercial development needs. Please contact us to discuss the documentation you need.
Q3: How should CTP Sodium Solution be stored and transported?
It should be transported below 0°C and stored at -25°C to -15°C. Customized specifications and supply solutions are available according to your research and manufacturing needs.
